arBtrage CAPITALIZING MARKETS checking… Sign in

Pliant Therapeutics, Inc.

PLRX Health Care Biotechnology: Pharmaceutical Preparations
$1.15
▼ -1.7% Today
as of Jun 7, 07:24 ET
Last 30 days -4.96% Apr 28 → Jun 05
$1.14 $1.17 $1.20 $1.24 $1.27 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.16
High
$1.18
Low
$1.13
Volume
$408,832
Avg Vol
$921,921
Mkt Cap
$77M
P/E (TTM)
Beta
52w High
$1.95
52w Low
$1.09
Div Yield
Shares Out
$62M

Overview

52-week range
$1.09
$1.95
7% of range
Avg surprise (last 2)
-7.5%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
1256%
EM ±173.9% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.95$-0.79$-0.64$-0.48$-0.32 Actual $-0.70Actual $-0.70Actual $-0.78Actual $-0.92Actual $-0.95Actual $-0.92Est $-0.73Actual $-0.71Actual $-0.43Actual $-0.32Est $-0.36 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-58M$-49M$-39M$-30M$-21M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.32 $-0.36 +11.1% +65.2% -1.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.43 financials
Mon Jun 30, 2025Jun 2025 $-0.71 financials
Thu May 8, 2025Mar/2025 $-0.92 $-0.73 -26.0% +2.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.95 financials
Sun Jun 30, 2024Jun 2024 $-0.92 financials
Sun Mar 31, 2024Mar 2024 $-0.78 financials
Sat Sep 30, 2023Sep 2023 $-0.70 financials
Fri Jun 30, 2023Jun 2023 $-0.70 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-22M$-28M$-46M$-59M$-62M$-61M
Net income$-20M$-26M$-43M$-56M$-58M$-56M
EPS (diluted)$-0.32$-0.43$-0.71$-0.92$-0.95$-0.92

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$22M$45M$94M$87M$92M$71M$80M$80M
Inventory
Total current assets$175M$196M$246M$267M$311M$362M$410M$448M
Total assets$203M$225M$277M$300M$345M$397M$446M$484M
Long-term debt$0$0$30M$30M$30M$30M$30M$30M
Total liabilities$37M$44M$76M$80M$88M$93M$100M$91M
Total equity$165M$181M$200M$220M$257M$304M$346M$393M

Implied volatility — last 90 days

1250%1253%1255%1258%1260% Jun 07 — IV 1256% · EM ±173.9%

Sector peers